I have heard in my region that about half of the abilify reps as well as dms are leaving to launch the new a-typical-is this really happening? How many territories are affected? will those positions be filled or eliminated? Can I just get some answers and not that strange guy who continues to complain about Paul and MCB?
I haven't heard of anyone from Osuka leaving for sunovion. Those jobs start on 11/29 so if people start to leave next week is when it would go down. I was offered a hospital position but turned it down. I did not think they were very solid on their understanding of the hospital environment and the dsm had yet received a list of accts. Didnt know if it would include prisons, the va, ltc, community mental health or just hospitals. They will sell under the title of something like zyprexa light. the efficacy but not the side effects. This will be based loosely on a placebo controlled trial with zyprexa as a comparitor. Of course you can not make comparisions or make efficacy conclusions with this trial but they will.
I hear that the DM from Arizona has gone over. Other than that, no one from the west that I have heard. I think our BMS partners are a little more jittery since they don't have anything lined up post-Abilify. It's always smart to be open to new opportunites, but this ain't one of them. My hope is that my SQL reps all go over - would make my Q1 much nicer!
Funny but I can name about 10 reps that got offers and over half took them-the best part is they will all wait till friday of thanksgiving to give their notice-brace yourself Otsuka -I bet you loose 20 percent of your sales force and in particular the well liked successful reps
Sunovion is putting a ton of resources behind Latuda. They were smart in hiring mostly people who were currently employed with AZ, Janssen, Lily, and BMS/OAPI reps. Those are the 4 most prescribed atypicals so they have put a veteran and experienced salesforce together to launch the drug. I also heard that Andrei Pikalov is with them now which is a major coup for them as well. I think any OAPI rep that left is smart. OAPI has been in a downward spiral for a couple of years now thanks to your current leadership. Sunovion is exactly what OAPI use to be - a smaller, privately owned Japanese pharmaceutical company with a robust pipeline and a management team that doesn't have an identity crisis. Plus they have the financial backing of Sepracor as well. Who wouldn't want to leave OAPI for that environment? Oh yeah, bottom feeders wouldn't want to leave.
I sold Seroquel, and I tried to get a job with another atypical. The manager didn't want to hire someone who had sold an atypical. He wanted to hire someone with relationships due to credibility. I guess I kind of don't blame him. But, I wanted to get out of AZ.
what kind of car do you get with Otsuka? Interview in CALI How often to MGR's ride with reps. once a month is too much. Harassment- once a quarter if tolerable.
